Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...